Literature DB >> 15761273

A review of rating scales for measuring behavior change due to frontal systems damage.

Paul Malloy1, Janet Grace.   

Abstract

OBJECTIVE: To perform a critical review of scales designed to measure frontal behavior change.
BACKGROUND: Changes in cognition due to frontal disease or damage have been well described, but noncognitive changes in behavior are often more deleterious functionally for frontal patients.
METHOD: The review concentrates on five behavior rating scales: the Behavior Rating Inventory of Executive Functions (BRIEF), the Dysexecutive Questionnaire (DEX), the Frontal Behavior Inventory (FBI), the Frontal Systems Behavior Scale (FrSBe), the Iowa Rating Scales of Personality Change (IRSPC), and the Neuropsychiatric Inventory (NPI). Other scales purporting to measure specific aspects of frontal functioning, but having less research support, are described briefly. RESULTS AND
CONCLUSIONS: The BRIEF and FrSBe have good reliability and large-scale norms. No norms are available for the other scales. The FrSBe and IRSPC have been shown to be valid in discriminating frontal from nonfrontal lesioned patients, but this has not been shown in the other scales. The FBI and NPI require trained raters, whereas the FrSBe, IRSPC, and BRIEF are administered to patients and/or family informants directly. The NPI and FBI are sensitive to certain changes in behavior attributed to frontal systems disruption but have been used primarily in dementia.

Entities:  

Mesh:

Year:  2005        PMID: 15761273     DOI: 10.1097/01.wnn.0000152232.47901.88

Source DB:  PubMed          Journal:  Cogn Behav Neurol        ISSN: 1543-3633            Impact factor:   1.600


  39 in total

1.  Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response.

Authors:  Theresa M Winhusen; Eugene C Somoza; Daniel F Lewis; Frankie B Kropp; Viviana Elizabeth Horigian; Bryon Adinoff
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

Review 2.  Assessing the interplay between cognition and gait in the clinical setting.

Authors:  A H Snijders; C C Verstappen; M Munneke; B R Bloem
Journal:  J Neural Transm (Vienna)       Date:  2007-07-06       Impact factor: 3.575

3.  Multicenter validation of a bedside antisaccade task as a measure of executive function.

Authors:  J Hellmuth; J Mirsky; H W Heuer; A Matlin; A Jafari; S Garbutt; M Widmeyer; A Berhel; L Sinha; B L Miller; J H Kramer; A L Boxer
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

4.  Executive functioning complaints and escitalopram treatment response in late-life depression.

Authors:  Kevin J Manning; George S Alexopoulos; Samprit Banerjee; Sarah Shizuko Morimoto; Joanna K Seirup; Sibel A Klimstra; Genevieve Yuen; Theodora Kanellopoulos; Faith Gunning-Dixon
Journal:  Am J Geriatr Psychiatry       Date:  2013-11-27       Impact factor: 4.105

5.  Preliminary evaluation of a model of stimulant use, oxidative damage and executive dysfunction.

Authors:  Theresa Winhusen; Jessica Walker; Gregory Brigham; Daniel Lewis; Eugene Somoza; Jeff Theobald; Veronika Somoza
Journal:  Am J Drug Alcohol Abuse       Date:  2013-06-28       Impact factor: 3.829

Review 6.  Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment.

Authors:  Thomas N Chase
Journal:  Neurotox Res       Date:  2010-05-15       Impact factor: 3.911

7.  Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances.

Authors:  Caitlin N Pope; Jessica L Montoya; Elizabeth Vasquez; Josué Pérez-Santiago; Ronald Ellis; J Allen McCutchan; Dilip V Jeste; David J Moore; María J Marquine
Journal:  J Neurovirol       Date:  2020-07-30       Impact factor: 2.643

8.  Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.

Authors:  Krista Lisdahl Medina; Paula K Shear
Journal:  Drug Alcohol Depend       Date:  2006-10-30       Impact factor: 4.492

9.  Sex differences in disinhibition and its relationship to physical abuse in a sample of stimulant-dependent patients.

Authors:  Theresa Winhusen; Daniel Lewis
Journal:  Drug Alcohol Depend       Date:  2012-10-11       Impact factor: 4.492

Review 10.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.